Literature DB >> 11823343

Hyperprolactinaemia caused by antipsychotic drugs.

Angelika Wieck, Peter Haddad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11823343      PMCID： PMC1122185          DOI： 10.1136/bmj.324.7332.250

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Clinical review 106: Amenorrheic bone loss.

Authors:  K K Miller; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia.

Authors:  K Ataya; A Mercado; J Kartaginer; A Abbasi; K S Moghissi
Journal:  Fertil Steril       Date:  1988-12       Impact factor: 7.329

3.  The behavioral toxicity of bromocriptine in patients with psychiatric illness.

Authors:  R M Perovich; J A Lieberman; W W Fleischhacker; J Alvir
Journal:  J Clin Psychopharmacol       Date:  1989-12       Impact factor: 3.153

4.  Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology.

Authors:  K Windgassen; U Wesselmann; H Schulze Mönking
Journal:  Neuropsychobiology       Date:  1996       Impact factor: 2.328

5.  The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea.

Authors:  P J Beumont; M G Gelder; G H Friesen; G W Harris; P C MacKinnon; B M Mandelbrote; D H Wiles
Journal:  Br J Psychiatry       Date:  1974-05       Impact factor: 9.319

6.  The effect of neuroleptics on serum prolactin in schizophrenic patients.

Authors:  H Y Meltzer; V S Fang
Journal:  Arch Gen Psychiatry       Date:  1976-03

7.  Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.

Authors:  A M Ghadirian; G Chouinard; L Annable
Journal:  J Nerv Ment Dis       Date:  1982-08       Impact factor: 2.254

8.  Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Biol Psychiatry       Date:  1985-11       Impact factor: 13.382

9.  Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism.

Authors:  S L Greenspan; D S Oppenheim; A Klibanski
Journal:  Ann Intern Med       Date:  1989-04-01       Impact factor: 25.391

Review 10.  Sexual side effects of antipsychotic medication: evaluation and interventions.

Authors:  G Sullivan; D Lukoff
Journal:  Hosp Community Psychiatry       Date:  1990-11
View more
  7 in total

1.  Hyperprolactinaemia caused by antipsychotic drugs. Endocrine antipsychotic side effects must be systemically assessed.

Authors:  Oliver Howes; Shubulade Smith
Journal:  BMJ       Date:  2002-05-25

2.  Treating symptomatic hyperprolactinemia secondary to a long-acting injectable atypical antipsychotic in a patient with bipolar disorder due to an anoxic brain injury.

Authors:  McLeod F Gwynette; Nick Evangelidis
Journal:  Prim Care Companion CNS Disord       Date:  2013

3.  Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.

Authors:  R Grohmann; R R Engel; H-J Möller; E Rüther; J W van der Velden; S Stübner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

4.  Health-related internet use by lupus patients in southern Spain.

Authors:  José-Luis Callejas-Rubio; Raquel Ríos-Fernández; Ana-Celia Barnosi-Marín; Francisco-José García-Hernández; José-Antonio Vargas-Hitos; María-Teresa Camps-García; José-Antonio González-Nieto; Julio Sánchez-Román; Juan Jiménez-Alonso; Enrique de Ramón Garrido; Norberto Ortego-Centeno; Norberto Otego-Centeno
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

5.  Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.

Authors:  Senthil K Muthuswamy
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

Review 6.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.